SEARCH

SEARCH BY CITATION

REFERENCES

  • Allanson JE. 1987. Noonan syndrome. J Med Genet 24:913.
  • Bentires-Alj M, Paez JG, David FS, Keilhack H, Halmos B, Naoki K, Maris JM, Richardson A, Bardelli A, Sugarbaker DJ, Richards WG, Du J, Girard L, Minna JD, Loh ML, Fisher DE, Velculescu VE, Vogelstein B, Meyerson M, Sellers WR, Neel BG. 2004. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 64:88168820.
  • Bertola DR, Pereira AC, Passetti F, de Oliveira PS, Messiaen L, Gelb BD, Kim CA, Krieger JE. 2005. Neurofibromatosis-Noonan syndrome:Molecular evidence of the concurrence of both disorders in a patient. Am J Med Genet Part A 136A:242245.
  • Brasil AS, Periera AC, Wanderley LT, Kim CA, Malaquias AC, Jorge AAL, Krieger JE, Bertola DR. 2010. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes. Genet Test Mol Biomarkers 14:425432.
  • Carvalho JF, Marchiori E, Zanetti G, Mano CM, Sarcinelli-Luz B, Vianna FG, Assed C, Santos IG, Santos AA, Vianna AD. 2010. Paravertebral mass in a patient with hemolytic anemia:Computed tomographic findings. Case Rep Med 2010:724279 [Epub 2010 Mar 25].
  • Chan G, Kalaitzidis D, Neel BG. 2008. The tyrosine phosphatase Shp2 PTPN11 in cancer. Cancer Metastasis Rev 27:179192.
  • Cirstea IC, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D, Roberts AE, Lepri F, Merbitz-Zahradnik T, König R, Kratz CP, Pantaleoni F, Dentici ML, Joshi VA, Kucherlapati RS, Mazzanti L, Mundlos S, Patton MA, Silengo MC, Rossi C, Zampino G, Digilio C, Stuppia L, Seemanova E, Pennacchio LA, Gelb BD, Dallapiccola B, Wittinghofer A, Ahmadian MR, Tartaglia M, Zenker M. 2010. A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet 42:2729.
  • Cordeddu V, Di Schiavi E, Pennacchio LA, Ma'ayan A, Sarkozy A, Fodale V, Cecchetti S, Cardinale A, Martin J, Schackwitz W, Lipzen A, Zampino G, Mazzanti L, Digilio MC, Martinelli S, Flex E, Lepri F, Bartholdi D, Kutsche K, Ferrero GB, Anichini C, Selicorni A, Rossi C, Tenconi R, Zenker M, Merlo D, Dallapiccola B, Iyengar R, Bazzicalupo P, Gelb BD, Tartaglia M. 2009. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 41:10221026.
  • Denayer E, de Ravel T, Legius E. 2008. Clinical and molecular aspects of RAS related disorders. J Med Genet 45:695703.
  • Digilio MC, Sarkozy A, Capolino R, Chiarini Testa MB, Esposito G, de Zorzi A, Cutrera R, Marino B, Dallapiccola B. 2008. Costello syndrome: Clinical diagnosis in the first year of life. Eur J Pediatr 167:621628.
  • Flotho C, Batz C, Hasle H, Bergsträsser E, van den Heuvel-Eibrink MM, Zecca M, Niemeyer CM, Zenker M. 2010. Mutational analysis of SHOC2, a novel gene for Noonan-like syndrome, in JMML. Blood 115:913.
  • Gripp KW, Scott CI Jr, Nicholson L, McDonald-McGinn DM, Ozeran JD, Jones MC, Lin AE, Zackai EH. 2002. Five additional Costello syndrome patients with rhabdomyosarcoma:Proposal for a tumor screening protocol. Am J Med Genet 108:8087.
  • Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. 2007. Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov 6:541555.
  • Martinelli S, De Luca A, Stellacci E, Rossi C, Checquolo S, Lepri F, Caputo V, Silvano M, Buscherini F, Consoli F, Ferrara G, Digilio MC, Cavaliere ML, van Hagen JM, Zampino G, van der Burgt I, Ferrero GB, Mazzanti L, Screpanti I, Yntema HG, Nillesen WM, Savarirayan R, Zenker M, Dallapiccola B, Gelb BD, Tartaglia M. 2010. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype. Am J Hum Genet 87:250257.
  • Mazzanti L, Cacciari E, Cicognani A, Bergamaschi R, Scarano E, Forabosco A. 2003. Noonan-like syndrome with loose anagen hair: A new syndrome? Am J Med Genet Part A 118A:279286.
  • Mutesa L, Pierquin G, Janin N, Segers K, Thomée C, Provenzi M, Bours V. 2008. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors. Cancer Genet Cytogenet 182:4042.
  • Nava C, Hanna N, Michot C, Pereira S, Pouvreau N, Niihori T, Aoki Y, Matsubara Y, Arveiler B, Lacombe D, Pasmant E, Parfait B, Baumann C, Héron D, Sigaudy S, Toutain A, Rio M, Goldenberg A, Leheup B, Verloes A, Cavé H. 2007. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway:Genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet 44:763771.
  • Nyström AM, Ekvall S, Berglund E, Björkqvist M, Braathen G, Duchen K, Enell H, Holmberg E, Holmlund U, Olsson-Engman M, Annerén G, Bondeson ML. 2008. Noonan and cardio-facio-cutaneous syndromes: Two clinically and genetically overlapping disorders. J Med Genet 45:500506.
  • Nyström AM, Ekvall S, Strömberg B, Holmström G, Thuresson AC, Annerén G, Bondeson ML. 2009. A severe form of Noonan syndrome and autosomal dominant cafe-au-lait spots - evidence for different genetic origins. Acta Paediatr 98:693698.
  • Razzaque MA, Nishizawa T, Komoike Y, Yagi H, Furutani M, Amo R, Kamisago M, Momma K, Katayama H, Nakagawa M, Fujiwara Y, Matsushima M, Mizuno K, Tokuyama M, Hirota H, Muneuchi J, Higashinakagawa T, Matsuoka R. 2007. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 39:10131017.
  • Sarkozy A, Carta C, Moretti S, Zampino G, Digilio MC, Pantaleoni F, Scioletti AP, Esposito G, Cordeddu V, Lepri F, Petrangeli V, Dentici ML, Mancini GM, Selicorni A, Rossi C, Mazzanti L, Marino B, Ferrero GB, Silengo MC, Memo L, Stanzial F, Faravelli F, Stuppia L, Puxeddu E, Gelb BD, Dallapiccola B, Tartaglia M. 2009. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes:Molecular diversity and associated phenotypic spectrum. Hum Mutat 30:695702.
  • Schubbert S, Shannon K, Bollag G. 2007. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7:295308.
  • Thiel C, Wilken M, Zenker M, Sticht H, Fahsold R, Gusek-Schneider GC, Rauch A. 2009. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. Am J Med Genet Part A 149A:12631267.
  • Tidyman WE, Rauen KA. 2009. The RASopathies:Developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19:230236.
  • van der Burgt I. 2007. Noonan syndrome. Orphanet J Rare Dis 2:4.
  • Zenker M, Voss E, Reis A. 2007. Mild variable Noonan syndrome in a family with a novel PTPN11 mutation. Eur J Med Genet 50:4347.